Skip to main content
. Author manuscript; available in PMC: 2011 Dec 2.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4138–4145. doi: 10.1167/iovs.05-1452

Figure 3.

Figure 3

Withanolide D inhibited angiogenic sprouting in 3D-ECSA. Endothelial cell spheroids from HUVECs and HCECs were treated with 10 ng/mL VEGF in the presence and absence of different concentrations of withanolide D (WD). The HCEC-derived sprouts and HUVEC-derived sprouts were photographed after 36 and 24 hours, respectively.